MorphoSys AG (MOR)
17.89
+0.38
(+2.17%)
USD |
NASDAQ |
May 02, 16:00
17.89
0.00 (0.00%)
After-Hours: 20:00
MorphoSys Shareholders Equity (Quarterly): 54.22M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 54.22M |
June 30, 2023 | 34.42M |
March 31, 2023 | 105.80M |
December 31, 2022 | 168.81M |
June 30, 2022 | -28.68M |
March 31, 2022 | 158.20M |
December 31, 2021 | 277.25M |
September 30, 2021 | 692.75M |
March 31, 2021 | 679.52M |
December 31, 2020 | 764.20M |
September 30, 2020 | 702.13M |
June 30, 2020 | 738.36M |
March 31, 2020 | 737.53M |
December 31, 2019 | 442.13M |
September 30, 2019 | 484.76M |
June 30, 2019 | 526.48M |
March 31, 2019 | 523.74M |
December 31, 2018 | 558.65M |
September 30, 2018 | 617.28M |
June 30, 2018 | 576.84M |
March 31, 2018 | 419.94M |
December 31, 2017 | 430.30M |
September 30, 2017 | 435.77M |
June 30, 2017 | 448.70M |
March 31, 2017 | 429.14M |
Date | Value |
---|---|
December 31, 2016 | 439.21M |
September 30, 2016 | 370.21M |
June 30, 2016 | 381.02M |
March 31, 2016 | 400.39M |
December 31, 2015 | 396.58M |
September 30, 2015 | 421.80M |
June 30, 2015 | 428.79M |
March 31, 2015 | 422.72M |
December 31, 2014 | 424.15M |
September 30, 2014 | 441.38M |
June 30, 2014 | 476.91M |
March 31, 2014 | 476.27M |
December 31, 2013 | 486.27M |
September 30, 2013 | 476.69M |
June 30, 2013 | 289.68M |
March 31, 2013 | 271.97M |
December 31, 2012 | 267.16M |
September 30, 2012 | 255.78M |
June 30, 2012 | 245.32M |
March 31, 2012 | 263.10M |
December 31, 2011 | 255.35M |
September 30, 2011 | 271.86M |
June 30, 2011 | 292.24M |
March 31, 2011 | 290.55M |
December 31, 2010 | 247.27M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-28.68M
Minimum
Jun 2022
764.20M
Maximum
Dec 2020
408.62M
Average
463.45M
Median
Shareholders Equity (Quarterly) Benchmarks
Incyte Corp | 5.394B |
Novartis AG | 39.68B |
Immatics NV | 248.81M |
Affimed NV | 63.90M |
InflaRx NV | 113.39M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 2.240B |
Total Liabilities (Quarterly) | 2.186B |
Debt to Equity Ratio | 12.71 |
Current Ratio | 3.080 |
Net Debt Paydown Yield | -9.26% |